论文部分内容阅读
目的探讨沐舒坦在小儿支气管肺炎治疗中的临床疗效。方法将肺炎诊断标准患儿86例随机分成两组,对照组给予抗生素,保持呼吸道通畅,止咳、平喘、镇静、吸氧,预防酸中毒和电解质紊乱等常规治疗。治疗组在常规治疗的基础上加沐舒坦治疗,小于2岁7.5 mg/次,2次/d静脉滴注;2~6岁7.5 mg/次,3次/d静脉滴注;6岁以上15 mg/次,2次/d静脉滴注;连续给药7 d后行疗效评定。结果治疗组咳嗽减轻时间、咳痰持续时间、罗音完全消失时间、治愈天数均低于对照组,差异有统计学意义(P<0.01);治疗组有效率93.02%,对照组有效率74.42%,差异有统计学意义(P<0.01)。结论沐舒坦是一种有效的祛痰药物,值得临床进一步推广使用。
Objective To investigate the clinical efficacy of mucosolvan in the treatment of bronchial pneumonia in children. Methods Eighty-six children diagnosed with pneumonia were randomly divided into two groups. Patients in the control group were given antibiotics to maintain airway patency, relieve cough, relieve asthma, sedative, oxygen inhalation, prevent acidosis and electrolytes disorders. The treatment group was treated with mucosolvan on the basis of routine treatment, 7.5 mg / time less than 2 years of age, 2 times / d intravenous infusion; 2 to 6 years old 7.5 mg / time, 3 times / d intravenous infusion; 6 years old 15 mg / time, 2 times / d intravenous infusion; continuous administration of 7d after curative effect evaluation. Results The treatment group cough relief time, duration of sputum, complete disappearance of rales, days of cure were lower than the control group, the difference was statistically significant (P <0.01); the effective rate was 93.02% in the treatment group and 74.42% in the control group , The difference was statistically significant (P <0.01). Conclusion Mucosolvan is an effective expectorant drug, it is worth further clinical use.